First Trust Dorsey Wright DALI股票ETF DALI 深 沪
已收盘 04-02 16:00:00 美东时间
28.0383
-0.177
-0.63%
华盛通- 最 高28.17
- 今 开27.45
- 成交量 9304股
- 最 低 27.45
- 昨 收 28.2149
- 总市值 1.07亿
- 52周最高 30.9488
- 市盈率 静 --
- 换手率 0.24%
- 52周最低 21.8828
- 委 比 77.78%
- 总股本 380.00万
- 历史最高 30.9488
- 量 比 1.10
- 振 幅 2.55%
- 历史最低 12.0599
- 每 手 1
- 风险率 2.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多How Smart Money Is Positioning To Win In 2026
The world's largest investors are making the same bet. If your portfolio still looks like it did in 2025, that's worth thinking about.
02-20 01:59
BRIEF-Medalist Diversified REIT To Change Name To Medalist Diversified
BRIEF-Medalist Diversified REIT To Change Name To Medalist Diversified Feb 17 (Reuters) - Medalist Diversified Reit Inc MDRR.O : MEDALIST DIVERSIFIED REIT, INC. ANNOUNCES CORPORATE REPOSITIONING MEDALIST DIVERSIFIED REIT INC - TO REVOKE REIT TAX ELECTION IN 2026 & TRANSITION TO STANDARD C-CORPORATI
02-18 05:33
BRIEF-China Vice Premier Meets Dimon, Cook, Dalio, Other CEO's In Davos - Bloomberg News
BRIEF-China Vice Premier Meets Dimon, Cook, Dalio, Other CEO's In Davos - Bloomberg News Jan 21 (Reuters) - CHINA VICE PREMIER MEETS DIMON, COOK, DALIO, OTHER CEOS IN DAVOS - BLOOMBERG NEWS Source text: https://tinyurl.com/36u6k44s Further company coverage: [AAPL.O JPM.N] (( Reuters.Briefs@thomsonre
01-22 04:07
BRIEF-Amgen Says Aimovig & Amjevita To Be Available At Discounted Monthly Price Of $299 Under Deal With U.S. Govt
Dec 19 (Reuters) - Amgen Inc AMGN.O: AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS AMGEN INC - INVESTED OVER $40 BILLION IN MANUFACTURING AND RESEARC...
2025-12-20 03:58
First Trust Dorsey Wright DALI 1 ETF declares $0.0352 dividend
First Trust Dorsey Wright DALI 1 ETF (DALI) declares $0.0352/share quarterly dividend. Payable Dec. 31; for shareholders of record Dec. 12; ex-div Dec. 12. See DALI Dividend Scorecard, Yield Chart, & ...
2025-12-12 22:51
BRIEF-Morningstar Announces Clearer, Simplified Medalist Rating To Empower Investor Success
Dec 4 (Reuters) - Morningstar Inc MORN.O: MORNINGSTAR ANNOUNCES CLEARER, SIMPLIFIED MEDALIST RATING TO EMPOWER INVESTOR SUCCESS Source text: ID:nBwbScHxya Further company coverage: MORN.O ((Reuters.Br...
2025-12-04 22:12
BRIEF-Abbvie To Feature New Data At ASH 2025
Dec 2 (Reuters) - Abbvie Inc ABBV.N: ABBVIE TO FEATURE NEW DATA AT ASH 2025 SHOWCASING CONTINUED ADVANCES ACROSS NOVEL TREATMENT MODALITIES IN MULTIPLE BLOOD CANCERS Source text: ID:nPnWt0CFa Further ...
2025-12-02 22:10
BRIEF-Bridgewater Founder Ray Dalio on Markets Says We Are At 80% Into A Bubble - CNBC Interview
Nov 20 (Reuters) - BRIDGEWATER FOUNDER RAY DALIO - I BELIEVE THAT WE HAVE A DEBT PROBLEM - CNBC INTERVIEW BRIDGEWATER FOUNDER DALIO - I THINK WE HAVE A CHALLENGE IN PRIVATE EQUITY MARKETS - CNBC INTER...
2025-11-20 21:32
BRIEF-GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
Nov 12 (Reuters) - GE Healthcare Technologies Inc GEHC.O: GE HEALTHCARE AND RADNET’S DEEPHEALTH DIVISION SIGN LETTER OF INTENT TO ADVANCE INNOVATION AND ADOPTION OF AI-POWERED IMAGING ACROSS MULTIPLE ...
2025-11-13 05:34
BRIEF-RINVOQ (upadacitinib)Demonstrated Superiority Versus HUMIRA (adalimumab)for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
Oct 20 (Reuters) - Abbvie Inc ABBV.N: RINVOQ® (UPADACITINIB) DEMONSTRATED SUPERIORITY VERSUS HUMIRA® (ADALIMUMAB) FOR PRIMARY ENDPOINT IN A HEAD-TO-HEAD STUDY IN RHEUMATOID ARTHRITIS PATIENTS WHO HAVE...
2025-10-20 20:05
